|
|
.
See Category: Diseases of the digestive system
ICD-10 (CM) Code and Descriptor
|
K43.9 |
Ventral hernia without obstruction or gangrene
|
K439 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 36.21%
|
18.85%
|
11.46%
|
8.19%
|
5.82%
|
4.50%
|
3.36%
|
2.55%
|
2.04%
|
1.53%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for K43.9*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
8,307
|
8,343
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
7,679
|
714,499
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
7,602
|
7,603
|
|
J2405
|
ONDANSETRON HCL INJECTION |
6,927
|
30,719
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
6,676
|
6,683
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
6,484
|
6,539
|
|
J3010
|
FENTANYL CITRATE INJECTION |
6,206
|
12,071
|
|
80053
|
COMPREHEN METABOLIC PANEL |
5,604
|
5,606
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
4,842
|
17,298
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
4,821
|
123,535
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
4,430
|
17,870
|
|
C1781
|
MESH (IMPLANTABLE) |
4,406
|
4,813
|
|
74176
|
CT ABD & PELVIS W/O CONTRAST |
4,127
|
4,130
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
4,066
|
23,929
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
3,941
|
27,154
|
|
83690
|
ASSAY OF LIPASE |
3,425
|
3,428
|
|
J1170
|
HYDROMORPHONE INJECTION |
3,329
|
5,763
|
|
80048
|
METABOLIC PANEL TOTAL CA |
3,143
|
3,149
|
|
93005
|
ELECTROCARDIOGRAM TRACING |
3,098
|
3,154
|
|
99284
|
EMERGENCY DEPT VISIT MOD MDM |
2,969
|
2,969
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
K43.9 related to the following DRG Codes:
393-395
|
